INSIGHTS ON SOLID DOSE MANUFACTURING

• Shaping The Future Of Solid Dose Manufacturing With Hot Melt Extrusion

  Enhance your drug development strategies today and master hot melt extrusion by learning about excipient selection, equipment setup, novel screening tools, and process optimization.

• Safely Scaling High Potency API Manufacturing

  Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.

• Delivering API-In-Capsule For Potent, Low-Flow Compounds

  See how an automated capsule-filling approach addressed poor-flow APIs, improved operator safety, and supported fast scale-up for clinical supply needs.

• HPAPIS Production: "Where Micrograms Matters"

  In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.

• Breaking The GLP-1 Manufacturing Bottleneck: Single Use For Safer Scale Up

  9/23/2026

  Streamline GLP-1 scale-up by replacing heavy container cleaning with single-use powder handling to boost containment and manufacturing capacity.

• How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions

  8/11/2025

  With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence

• Innovations In Orally Disintegrating Tablets For Pediatric Drug Delivery

  1/27/2025

  Delve into the evolving landscape of pediatric dosage forms, with a focus on how ODTs are emerging as a specialized and practical drug delivery system for children.

• Containment Solutions For API Weighing And Dispensing In Pharmaceutical Manufacturing

  9/30/2026

  Potency bands and exposure limits are a starting point for containment selection, not the answer. Quantity, dustiness, transfer method and process energy determine whether a control fits weighing and dispensing.

• Compaction Simulation For Tablet Technology Transfer And Scale-Up

  7/15/2026

  Compaction simulation de-risked tech transfer for a 40 mg fexuprazan tablet by defining optimal roller compaction and lubrication parameters before scale-up. Access the full case study to see the data.